| Date | Title | Description |
| 14.01.2025 | GenScript upgrades product packaging with a recyclable strategy, reducing waste by 82% and contributing to environmental sustainability | PISCATAWAY, N.J., Jan. 14, 2025 /PRNewswire/ -- GenScript Biotech Corporation has unveiled an innovation in shipping packaging, propelling GenScript towards achieving their ambitious sustainability goals. The new packaging replaces plastic ... |
| 08.01.2025 | GenScript Biotech Becomes a PSCI Supplier Partner, Advancing a Sustainable Pharmaceutical Supply Chain | PISCATAWAY, N.J., Jan. 8, 2025 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences research and manufacturing services, has officially joined the Pharmaceutical Supply Chain Initiative (PSCI) as a Supplier Partne... |
| 27.11.2024 | Solutions for Vaccine Innovation and Gene Therapy: Unlocking the Power of RNA, Upcoming Webinar Hosted by Xtalks | www.genscript.com
In this free webinar, learn about the fundamentals and applications of RNA technologies. Attendees will learn how self-amplifying RNA (saRNA) is advancing vaccine and gene therapy development. The featured speaker will dis... |
| 26.11.2024 | Cilia Proteins: The New Frontier in Vascular Health Monitoring | In the intricate world of human biology, cilia are often overlooked. These tiny, hair-like structures are more than mere cellular decorations. They play a pivotal role in sensing blood flow and maintaining vascular health. Recent advancemen... |
| 25.11.2024 | Cilia Proteins as Biomarkers of Vascular Health, Upcoming Webinar Hosted by Xtalks | www.genscript.com
In this free webinar, learn about the latest developments related to the biomarker potential of cilia and their potential clinical applications. Attendees will learn about the role of endothelial cilia as blood flow sensor... |
| 21.11.2024 | The GenScript Biotech Global Forum Makes a Strong Debut in Europe, Highlighting Breakthroughs in Cell and Gene Therapy Development | LONDON, Nov. 21, 2024 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the European debut of its GenScript Biotech Global Forum in London, UK. Since its ... |
| 14.11.2024 | GenScript Biotech: Pioneering the Future of Biotechnology | In the ever-evolving landscape of biotechnology, GenScript Biotech Corporation stands as a beacon of innovation. With its recent initiatives, the company is not just keeping pace; it is setting the rhythm. From global forums to local logist... |
| 13.11.2024 | Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies. | PISCATAWAY, N.J., Nov. 13, 2024 /PRNewswire/ -- The global cell and gene therapy (CGT) industry is poised for remarkable growth, driven by significant advances in life sciences and robust investments from capital markets. To strengthen this... |
| 11.11.2024 | GenScript Biotech Sets Up New Operations and Logistics Hub in Sydney, Australia | PISCATAWAY, N.J., Nov. 11, 2024 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript"), a global leader in life sciences services and products, has announced the establishment of new operations site and logistics center in Sy... |
| 25.10.2024 | Innovations in Drug Delivery: A Leap Towards the Future | In the ever-evolving landscape of healthcare, innovation is the lifeblood that keeps the industry vibrant. Recently, two significant events showcased groundbreaking advancements in drug delivery and biopharmaceuticals. The PDA Universe of P... |
| 24.10.2024 | Global Biopharma Thought Leaders Gather in London: Join the 2024 GenScript Biotech Global Forum for Cutting-Edge Insights | PISCATAWAY, N.J., Oct. 24, 2024 /PRNewswire/ -- Cell therapy, gene therapy, and mRNA vaccines are revolutionizing healthcare, offering innovative treatments for a wide range of diseases. However, as these therapies progress, they encounter ... |
| 16.10.2024 | Join the GenScript Biotech Global Forum: Unlocking Innovations in Cell and Gene Therapies | PISCATAWAY, N.J., Oct. 16, 2024 /PRNewswire/ -- The global cell and gene therapy (CGT) industry is poised for remarkable growth, driven by significant advances in life sciences and robust investments from capital markets. To strengthen this... |
| 11.10.2024 | The Rising Tide of Sustainability: How Companies Are Adapting to New Standards | In the world of business, sustainability is no longer a buzzword. It’s a necessity. Companies are feeling the heat. Stakeholders demand transparency. Customers want to know where their products come from. Investors are looking for responsib... |
| 11.10.2024 | The Future of Protein Research and Gene Editing: A New Era of Innovation | In the world of biotechnology, two upcoming virtual events are set to illuminate the path forward in protein research and gene editing. Bio-Techne and Labroots are leading the charge, showcasing innovations that promise to reshape our under... |
| 11.10.2024 | GenScript Biotech Advances Sustainable Development with MSCI ESG Rating Upgrade to A | PISCATAWAY, N.J., Oct. 11, 2024 /PRNewswire/ -- GenScript Biotech Corporation has recently been upgraded to an A rating in its Environmental, Social, and Governance (ESG) score by MSCI, a globally recognized rating agency. This upgrade refl... |
| 10.10.2024 | Unlocking CRISPR: Advances in Base Editing, Prime Editing and Future Applications, Upcoming Webinar Hosted by Xtalks | www.genscript.com
In this free webinar, explore the future of CRISPR and gene editing and discover how base and prime editing are poised to revolutionize the field of genetics. Attendees will learn about the mechanisms behind base editor an... |
| 10.10.2024 | Labroots to Host 7th Annual CRISPR Virtual Event Series on October 23rd, 2024 | Labroots 2024 CRISPR Virtual Event
Exploring incredible insights in CRISPR research and what makes it a vital scientific field that conducts cutting-edge research for gene editing, drug discovery, and technology advancements towards combatt... |
| 30.09.2024 | Maximizing PK and ADA Evaluation Efficiency Using Cutting-Edge Rabbit Antibody Development Technology: An Upcoming Webinar Hosted by Xtalks | www.genscript.com
In this free webinar, learn about the relevance of anti-idiotypic antibodies (anti-ID Abs) in antibody development. Attendees will learn why rabbits are the preferred host for generating high-performance anti-ID Abs. The f... |
| 19.09.2024 | Boost CRISPR Editing Efficiency Using Optimized sgRNA and HDR Template Design, Upcoming Webinar Hosted by Xtalks | www.genscript.com
In this free webinar, learn about the process and skills needed to design single guide RNA (sgRNA) and homology-directed pair (HDR) templates with high editing efficiency and low off-target effects. Attendees will learn ho... |
| 15.09.2024 | Dialogue with CGT Leaders! You Are Invited to Join the "2024 GenScript Biotech Global Forum•London" to Discuss the Future Together | PISCATAWAY, N.J., Sept. 15, 2024 /PRNewswire/ -- The year 2024 marks a milestone year for continuous advancements in Cell and Gene Therapy (CGT). The global launch of Amtagvi, a Tumor-Infiltrating Lymphocyte (TIL) therapy, has ushered in a ... |
| 12.09.2024 | GenScript Appoints New Board Members to Drive Global Growth | PISCATAWAY, N.J., Sept. 12, 2024 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript"), a global leader in life sciences products and services, announced the appointment of Dr. Ross Allen Grossman as a Non-Executive Director... |
| 29.08.2024 | Unlock the Full Potential of Cell and Gene Therapies: The 2024 GenScript Biotech Global Forum Heads to London | PISCATAWAY, N.J., Aug. 29, 2024 /PRNewswire/ -- The cell and gene therapy (CGT) industry has witnessed remarkable growth in recent years. According to an analysis by RSM US LLP, CGT therapies accounted for 10% of all FDA-approved drugs last... |
| 27.08.2024 | GenScript Subsidiary Legend Biotech Achieves Breakthrough with Cilta-cel Approval in China, Offering New Hope for Multiple Myeloma Patients | PISCATAWAY, N.J., Aug. 27, 2024 /PRNewswire/ -- Legend Biotech (NASDAQ: LEGN), a subsidiary of GenScript Biotech Corporation (hereinafter referred to as "GenScript"), a global leader in life sciences research and manufacturing ser... |
| 21.08.2024 | GenScript Launches Global Philanthropy Platform: The GenTeer Program | PISCATAWAY, N.J., Aug. 21, 2024 /PRNewswire/ -- On August 19, GenScript Biotech Corporation (referred to as GenScript) officially launched the "GenTeer (GenScript Volunteer) Program," an innovative global philanthropy platform. Th... |
| 12.08.2024 | The Power of DNA Mutant Libraries: Accelerating Revolution in Research, Upcoming Webinar Hosted by Xtalks | www.genscript.com
In this free webinar, learn how DNA mutant libraries are revolutionizing biomedical research. Attendees will learn about the impact and application of DNA mutant libraries on gene and cell therapy (e.g., sgRNA library, CAR... |
| 09.08.2024 | GenScript Biotech Reports First Half 2024 Results | Strong Revenue Growth and Strategic Advances Across Key Segments, Enhances Commitment to ESG and Sustainable Development
Impressive Financial Growth: The group reported a 43.5% increase in revenue, driven by a 156% boost in cell therapy rev... |
| 22.07.2024 | Duke-NUS launches LIVE Ventures, a S$20 million incubator to accelerate research commercialisation | New incubator aims to tap industry experts to bridge the knowledge and funding gap to enhance bench-to-bedside success
LIVE Ventures provides up to $500,000 for high-potential academic research projects
SINGAPORE, July 22, 2024 /PRNewswire/... |
| 16.07.2024 | GenScript Announces 4th Annual Gene & Cell Engineering Virtual Summit | GenScript 4th Annual Gene & Cell Engineering Virtual Summit
GenScript, the leading biotech company focused on early drug discovery and development services, is excited to announce its upcoming virtual event, the "GenScript 4th Annu... |
| 10.07.2024 | Azzur Group Appoints Two New Laboratory Directors | HATBORO, Pa., July 10, 2024 /PRNewswire/ -- Azzur Group today announces the appointment of new leadership for its cGMP microbiology and analytical laboratories. Joy Ghosh, PhD, has been named Senior Director, Laboratory Services in Schnecks... |
| 25.06.2024 | Accelerating Cell and Gene Therapy Success with cGMP Gene Editing Components and Regulatory Compliance, Upcoming Webinar Hosted by Xtalks | www.genscript.com
In this free webinar, take a deep dive into the distinctions between research use only (RUO), preclinical and clinical grades and how these affect gene editing components in cell and gene therapy development. Review case s... |
| 10.06.2024 | AI-based Antibody Therapeutics Developability Assessment and Its Engineering, Upcoming Webinar Hosted by Xtalks | www.genscript.com
In this free webinar, gain insights into the importance of bioinformatics research in the developability in antibody therapeutics. Attendees will learn how artificial intelligence (AI)-based platforms can transform develop... |
| 03.06.2024 | Bispecific Antibody Therapeutics: Challenges and Future Directions, Upcoming Webinar Hosted by Xtalks | www.genscript.com
In this free webinar, learn about the unique functionalities of bispecific antibodies (bsAbs) in targeting two antigens simultaneously, including insights into diverse bsAbs architectures and strategies for efficient produ... |
| 24.04.2024 | GenScript Biotech Releases 2023 ESG Report: Deepening Green Development Practices, Constructing Sustainable Future Blueprint | PISCATAWAY, N.J., April 24, 2024 /PRNewswire/ -- Recently, GenScript Biotech Corporation (HK.1548), a world leader in technologies and services for life science R&D and manufacture, released its 2023 Environmental, Social, and Governanc... |
| 23.04.2024 | Harnessing mRNA Immunization Strategy for Challenging GPCR Protein Antibody Discovery, Upcoming Webinar Hosted by Xtalks | www.genscript.com
In this free webinar, learn how an mRNA immunization strategy opens a new avenue in the antibody production of difficult protein targets and accelerates the development of antibody drugs against difficult-to-express target... |
| 15.04.2024 | GenScript Biotech officially joins SBTi to fulfill its sustainability commitment | PISCATAWAY, N.J., April 15, 2024 /PRNewswire/ -- On April 15, GenScript Biotech Corporation ("GenScript"), a world's leading technology and service provider of life science R&D and manufacture, announced that it has joined The... |
| 12.01.2024 | San Francisco Witnesses the Voice of GCT Titans GenScript Biotech Global Forum Outlines the Future of the Industry | SAN FRANCISCO, Jan. 12, 2024 /PRNewswire/ -- Every January, the global medical health and financial investment sectors turn their focus to San Francisco. The J.P. Morgan Healthcare Conference has been successfully held here for 42 editions,... |
| 04.01.2024 | GenScript Biotech Global Forum 2024 to Commence, Infusing New Vitality into the GCT Industry | NANJING, China, Jan. 4, 2024 /PRNewswire/ -- On January 10, 2024, the GenScript Biotech Global Forum is set to inaugurate with grandeur during the 42nd J.P. Morgan Healthcare Conference in San Francisco, USA. The forum, themed "Innovat... |
| 04.01.2024 | GenScript, GenScript ProBio, and Legend Biotech Will Attend the 42nd JPM Healthcare Conference, Advancing Innovation and Development in the Healthcare Sector | NANJING, China, Jan. 4, 2024 /PRNewswire/ -- GenScript Biotech, a global leader in life science research and manufacturing services, along with its subsidiaries GenScript ProBio and Legend Biotech, will be attending the 42nd JPM Healthcare ... |
| 25.12.2023 | FDA Keynote Speaker in the Spotlight, CAR-T Industry Leaders Gather for Discussion-Join the 2024 GenScript Biotech Global Forum for a New Journey in Cell and Gene Therapy | NANJING, China, Dec. 25, 2023 /PRNewswire/ -- The innovative development of biopharmaceuticals has ushered in a new era for disease treatment, bringing unprecedented hope to countless patients. However, the transition from basic research to... |
| 14.12.2023 | Titans Gather, Future Embarks: The GenScript Biotech Global Forum coinciding with the 2024 J.P. Morgan Healthcare Conference in San Francisco to Convene 20+ KOLs, Exploring Disruptive Transformations ... | Keynote speaker Peter Marks to Deliver Address Free Early Bird Registration Closing Soon
NANJING, China, Dec. 14, 2023 /PRNewswire/ -- Technological advancements continuously empower the life sciences. Gene and cell therapy (GCT), as breakt... |
| 07.12.2023 | CRISPR Continuous to Innovate! Exploring the Future of Cell & Gene Therapy, Industry Leaders Converge at the 2024 GenScript Biotech Global Forum | NANJING, China, Dec. 7, 2023 /PRNewswire/ -- The rapid advancement of technology has propelled the field of life sciences into unprecedented growth, constantly expanding our understanding and imagination. Particularly in the field of cellul... |
| 19.07.2023 | GenScript Biotech Corporation Presents the 3rd Annual Gene and Cell Engineering Summit | GenScript's 3rd Annual Gene and Cell Engineering Virtual Summit
PISCATAWAY, N.J. (PRWEB) July 19, 2023
GenScript Biotech Corporation, a world-leading biotech company offering comprehensive solutions in gene, peptide, protein, and antibody r... |
| 01.05.2023 | Anti-Idiotypic Antibody Platforms for Accelerating Antibody Drug Discovery, Upcoming Webinar Hosted by Xtalks | Advanced antibody discovery platforms and innovative techniques for antibody functional screening contribute to accelerating and improving the success rates in current therapeutics development.
TORONTO, Ontario, Canada (PRWEB) May 01, 2023
... |
| 18.11.2022 | GenScript takes home Executive of the Year - Biotechnology at the SBR Management Excellence Awards 2022 | Mr. Johnson Wang has propelled the GenScript APAC team to achieve numerous milestones despite external challenges.
SINGAPORE, Nov. 18, 2022 /PRNewswire/ -- Global biotechnology corporation, GenScript Asia Pacific's President, Mr. Johnson Wa... |
| 17.11.2022 | Startup Cradle Lets You Design Custom Proteins By Just Typing In A Prompt | Cradle Team at their site in the Netherlands.Cradle |
| 01.11.2022 | GenScript Supported Nasal Spray Development for COVID-19 Protection with GMP-grade Antibodies and Subsequently Planned for Long-Term Collaboration with Biogenexis | SINGAPORE, Nov. 1, 2022 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a leading global biotechnology company supported Chulalongkorn University, a research-intensive university in Thailand in de... |
| 15.09.2022 | GenScript Receives Best Cell & Gene Therapy Supplier Award: Gene Editing and GenScript ProBio Receives Best Biologics CMO Awards: Upstream Processing & Analytical Services | SINGAPORE, Sept. 15, 2022 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK) and GenScriptProBio (a global one-stop CDMO from GenScript Group) receive 3 awards: Best Cell & Gene Therapy Supplier A... |
| 04.08.2022 | Automated High-Throughput Protein and Antibody Purification — A Scalable and Cost-Effective Solution, Upcoming Webinar Hosted by Xtalks | Magnetic beads-based technology can be easily extended to a high-throughput purification system, providing significant savings in time and labor.
TORONTO (PRWEB) August 04, 2022
High-throughput purification is a critical step for antibody e... |
| 21.07.2022 | Genscript to Host their 2nd “Gene and Cell Engineering Summit,” July 28, 2022 | Genscript to Host their 2nd “Gene and Cell Engineering Summit,” July 28, 2022
PISCATAWAY, N.J. (PRWEB) July 21, 2022
Genscript to host their 2nd “Gene and Cell Engineering Summit” on July 28th 2022, on the Labroots platform.
At Genscript’s ... |
| 26.05.2022 | GenScript Biotech Collaborates with Singapore Institute of Technology on Talent Development and Applied Research Projects | Singapore, May 26, 2022 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK) and the Singapore Institute of Technology (SIT) signed a Memorandum of Understanding (MoU) today to develop Continuing Educat... |
| 30.03.2022 | GenScript Receives "Best Contract Development and Manufacturing Organization Award" For the Third Time in a Row | SINGAPORE, March 30, 2022 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK) receives the "Best Contract Development and Manufacturing Organization Award" on the Asia Pacific Bioprocessing E... |
| 29.03.2022 | Recombinant Protein Expression in the Pharmaceutical Industry: Success in CHO, Upcoming Webinar Hosted by Xtalks | The CHO system is favored for its resilience to variations in growth conditions and resistance to infections.
TORONTO (PRWEB) March 29, 2022
This webinar will focus on the use of the Chinese Hamster Ovary (CHO) system in the pharmaceutical ... |
| 10.02.2022 | GenScript Sets Up State-Of-Art Manufacturing Facility in Singapore to Strengthen Manufacturing Capability | SINGAPORE, Feb. 10, 2022 /PRNewswire/ -- GenScript Biotech Corporation (Stock Code: 1548.HK), the world's leading life science research tools and services provider, today announced the opening of more than 30,000-square-feet facility for hi... |
| 15.12.2021 | GenScript Receives "COVID Management Initiative of the Year" in Singapore Business Review Management Excellence Award 2021 | SINGAPORE, Dec. 15, 2021 /PRNewswire/ -- GenScript receives the award on COVID Management Initiative of the Year, Biotechnology industry in the Singapore Business Review (SBR) Management Excellence Award 2021. GenScript showed strong commit... |
| 01.12.2021 | GenScript and BioComo Join Forces to Accelerate Novel Intranasal SARS-CoV-2 Vaccine Development in Japan | TOKYO and SINGAPORE, Dec. 1, 2021 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a leading global biotechnology company, and BioComo Incorporation, a drug discovery venture based in Mie prefectur... |
| 30.11.2021 | Genscript Biotech : Launches Closed-End Double-Stranded DNA Service for CRISPR | Nov 11, 2021
PISCATAWAY, NEW JERSEY, Nov. 11, 2021 - GenScript USA Inc., the world's leading life science research tools and services provider, announced today that it has launched the GenWand™ Double-Stranded DNA (dsDNA) Service for the ma... |
| 17.11.2021 | OncoOne and GenScript ProBio Enter Agreement for the Manufacturing of Monoclonal Antibody Drugs Targeting oxMIF | SINGAPORE, Nov. 17, 2021 /PRNewswire/ -- OncoOne, a biotechnology company focused on discovering precision medicines for cancer and other indications and GenScript ProBio, a leading CDMO in biologics and gene cell therapy, today announced t... |
| 17.11.2021 | OncoOne and GenScript ProBio Enter Agreement for the Manufacturing of Monoclonal Antibody Drugs Targeting oxMIF | NANJING, China, Nov. 17, 2021 /PRNewswire/ -- OncoOne, a biotechnology company focused on discovering precision medicines for cancer and other indications and GenScript ProBio, a leading CDMO in biologics and gene cell therapy, today announ... |
| 12.11.2021 | GenScript Launches Closed-End Double-Stranded DNA Service for CRISPR | PISCATAWAY, N.J., Nov. 12, 2021 /PRNewswire/ -- GenScript USA Inc., the world's leading life science research tools and services provider, announced today that it has launched the GenWand™ Double-Stranded DNA (dsDNA) Service for the manufac... |
| 02.11.2021 | GenScript Expands Commercial Production in U.S. with State-of-the-Art Gene Synthesis Center | PISCATAWAY, New Jersey, Nov. 2, 2021 /PRNewswire/ -- GenScript USA Inc., the world's leading life science research tools and services provider, announced today that it has opened a larger than 50,000-square-foot facility for highly automate... |
| 02.11.2021 | GenScript Expands Commercial Production in U.S. with State-of-the-Art Gene Synthesis Center | PISCATAWAY, New Jersey, Nov. 2, 2021 /PRNewswire/ -- GenScript USA Inc., the world's leading life science research tools and services provider, announced today that it has opened a larger than 50,000-square-foot facility for highly automate... |
| 05.10.2021 | GenScript establishes Korean legal entity and accelerates sales activities | SEOUL, South Korea, Oct. 5, 2021 /PRNewswire/ -- GenScript, a global biotech company, recently completed the establishment of a legal entity called "GenScript Biotech Korea Ltd." and began to strengthen its sales activities in Kor... |
| 24.08.2021 | GenScript Biotech : Reports First Half 2021 Results | In the first half of 2021, the Group reported a revenue of approximately USD 229.6 million, a 38.0% YoY increase, and a gross profit of USD 138.6 million, achieving a 28.1% YoY growth. All four of the Group's business segments demonstrated ... |
| 24.08.2021 | GenScript Biotech Reports First Half 2021 Results | In the first half of 2021, the Group reported a revenue of approximately USD 229.6 million, a 38.0% YoY increase, and a gross profit of USD 138.6 million, achieving a 28.1% YoY growth. All four of the Group's business segments demonstrated ... |
| 03.08.2021 | GenScript Joins Forces with Allozymes by Providing Smart Libraries Construction for Precision Protein Engineering | SINGAPORE, Aug. 3, 2021 /PRNewswire/ -- GenScript Biotech Corporation (Stock Code: 1548.HK) today announced a collaboration with Allozymes, a synthetic biology company transforming ingredient manufacturing by unlocking protein engineering p... |
| 28.07.2021 | GenScript Announces Notice of Allowance for U.S. Patent Application for SARS-CoV-2 Surrogate Virus Neutralization Kit | PISCATAWAY, N.J., July 28, 2021 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world-leading life sciences research and application service and product provider, announced today that the U.S. P... |
| 28.07.2021 | GenScript Announces Notice of Allowance for U.S. Patent Application for SARS-CoV-2 Surrogate Virus Neutralization Kit | |
| 15.07.2021 | GenScript’s First Gene & Cell Engineering Virtual Summit, Produced by Labroots, Opens July 22, 2021 | GenScript’s First Gene & Cell Engineering Virtual Summit, Produced by Labroots, Opens July 22, 2021.
YORBA LINDA, Calif. (PRWEB) July 15, 2021
The GenScript Gene & Cell Engineering Virtual Summit is being held July 22, 2021 and will... |
| 13.07.2021 | GenScript to Host Gene & Cell Engineering Virtual Summit | PISCATAWAY, N.J. , July 13, 2021 /PRNewswire/ -- GenScript®, the world's leading life science service provider, announced today the first GenScript Gene & Cell Engineering Virtual Summit, featuring in-depth discussions and research pres... |
| 13.07.2021 | GenScript to Host Gene & Cell Engineering Virtual Summit | |
| 13.07.2021 | GenScript : to Host Gene & Cell Engineering Virtual Summit | PISCATAWAY, N.J. , July 13, 2021 /PRNewswire/ -- GenScript®, the world's leading life science service provider, announced today the first GenScript Gene & Cell Engineering Virtual Summit, featuring in-depth discussions and research pres... |
| 25.06.2021 | GenScript receives "Best Contract Development and Manufacturing Organization Award" in the Korea Bioprocessing Excellence Awards 2021 | SINGAPORE, June 25, 2021 /PRNewswire/ -- GenScript receives the "Best Contract Development and Manufacturing Organization Award" on the Korea Bioprocessing Excellence Awards 2021 held on 24th June 2021. GenScript achieve the Best ... |
| 21.06.2021 | Duke-NUS and GenScript Announce Notice of Allowance for U.S. Patent Application for SARS-CoV-2 Surrogate Virus Neutralization Test | PISCATAWAY, N.J. and SINGAPORE, June 21, 2021 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world-leading life sciences research and application service and product provider, and Duke-NUS Medi... |
| 28.04.2021 | GenScript Launches Research-Grade Lentiviral Vector Packaging Service | |
| 28.04.2021 | GENSCRIPT BIOTECH CORPORATION
GenScript : Launches Research-Grade Lentiviral Vector Packaging Service | PISCATAWAY, N.J., April 28, 2021 /PRNewswire/ -- GenScript®, the world's leading reagents provider, announced today the launch of its Research Lentiviral Vector Packaging Service for cell line development, gene editing, and drug discovery. ... |
| 13.04.2021 | Molecular Matrix and GenScript Partner to Launch SARS-CoV-2 Neutralizing Antibody Testing Service for Public | |
| 13.04.2021 | Molecular Matrix and GenScript Partner to Launch SARS-CoV-2 Neutralizing Antibody Testing Service for Public | PISCATAWAY, New Jersey and WEST SACRAMENTO, Calif., April 13, 2021 /PRNewswire/ -- Molecular Matrix, Inc. (MMI) and GenScript Biotech Corp. announced today that they have partnered to offer GenScript's SARS-CoV-2 neutralizing antibody test ... |
| 16.02.2021 | Development and Characterization of Monoclonal Antibodies Against AMPylation, Upcoming Webinar Hosted by Xtalks | This webinar will focus on the development of monoclonal anti-AMP antibodies in mice, as part of a collaborative effort with GenScript, that was recently published in iScience.
TORONTO (PRWEB) February 16, 2021
Post-translational modificati... |
| 11.02.2021 | GenScript Receives FDA Emergency Use Authorization for Use of cPass(TM) SARS-CoV-2 Neutralization Antibody Test in Convalescent Plasma Screening | |
| 13.01.2021 | GenScript Submits Application with FDA for Use of cPass™ SARS-CoV-2 Neutralization Antibody Test in Convalescent Plasma Screening | |
| 09.11.2020 | GenScript Receives FDA Emergency Use Authorization for World's First SARS-CoV-2 Neutralizing Antibody Detection Kit | |
| 25.09.2020 | Innatoss Laboratories udostępniają w Europie możliwość robienia badań pod kątem przeciwciał neutralizujących SARS-CoV-2 przy pomocy opracowanego przez GenScript zestawu cPass™
Polska - Polski
Россия... | |
| 18.09.2020 | Innatoss Laboratories lanza un servicio de test de anticuerpos neutralizantes de SARS-CoV-2
España - español
USA - English
USA - English
USA - English
USA - English
Slovensko - slovenčina
Deuts... | |
| 18.09.2020 | Laboratóriá Innatoss spustili verejnú testovaciu službu pre neutralizáciu protilátok pre SARS-CoV-2 v Európe pomocou súpravy GenScript cPass ™
Slovensko - slovenčina
USA - English
USA - English
US... | |
| 17.09.2020 | Innatoss Laboratories přichází na evropský trh s veřejnou službou na testování protilátek na SARS-CoV-2 se sadou GenScript's cPass™
Česko - čeština
USA - English
USA - English
USA - English
USA -... | |
| 16.09.2020 | Innatoss Laboratories внедряет общедоступный сервис тестирования на нейтрализующие антитела к вирусу SARS-CoV-2 в Европе с использованием тест-системы cPass™ фирмы GenScript
Россия - Pусский
USA - E... | |
| 15.09.2020 | Innatoss Laboratories Launches Neutralizing Antibody Public Testing Service for SARS-CoV-2 in Europe using GenScript's cPass™ kit
USA - English
USA - English
USA - English
USA - English
España - ... | |
| 18.09.2015 | Beyond The $1K Genome: DNA ‘Writing’ Comes Next | Emily Leproust Contributor
Emily Leproust is CEO of Twist Bioscience.
More posts by this contributor
Beyond The $1K Genome: DNA ‘Writing’ Comes Next
The “$1,000 genome” has been one of the most visible tech goals in the last 10 years, even ... |
